AngioDynamics, Inc. ANGO
15.49
0.21
1.37%
as of 25 Sep
- Market cap
- $631.6M
- P/E
- 0.0×
Follow ANGO
Insider Buys
alert about insiders buying in the last 12 month
| May '26 | Feb '26 | Nov '25 | Aug '25 | Older periods | |
|---|---|---|---|---|---|
| (20.77%) | (17.47%) | (15.26%) | (17.10%) |
+8 more TTM periods Free account |
|
| (13.43%) | (11.50%) | (9.87%) | (11.48%) | ||
ROIC |
(21.34%) | (16.38%) | (15.10%) | (16.74%) | |
Return on Tangible Assets |
(31.74%) | (26.46%) | (23.11%) | (26.87%) | |
Average Days of Receivables |
55.09 | 53.00 | 52.78 | 51.76 | |
Free Cash Flow per Share |
0.01 | 0.04 | (0.22) | (0.29) | |
Free Cash Flow |
0.51 | 1.50 | (9.33) | (11.89) | |
Capital Expenditures |
(2.58) | (2.94) | (3.73) | (4.10) | |
Piotroski F-Score |
4.00 | 6.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
1.37% | 2.11% | (2.57%) | (3.58%) | |
Accounts Receivable Turnover |
7.02 | 6.64 | 7.02 | 7.32 | |
Accounts Payable Turnover |
4.48 | 4.83 | 3.98 | 4.37 | |
Inventory Turnover |
2.54 | 2.36 | 2.12 | 2.17 | |
Average Days of Payables |
79.17 | 74.09 | 92.54 | 84.40 | |
Days of Inventory on Hand |
131.74 | 149.11 | 171.45 | 164.80 | |
Tax Rate |
0.01 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
9.20% | 8.88% | 9.01% | 8.76% | |
Selling, General and Administrative Expense of Revenue |
49.06% | 48.57% | 48.88% | 49.66% | |
Share Based Compensation of Revenue |
4.36% | 3.72% | 3.71% | 3.67% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.08) | (0.14) | 0.20 | 0.24 | |
Depreciation/Fixed assets |
0.85 | 0.80 | 0.78 | 0.81 | |
Capex/Depreciation |
(0.11) | (0.13) | (0.16) | (0.16) | |
Revenue per Share |
7.71 | 7.54 | 7.40 | 7.30 | |
Operating CF per Share |
0.07 | 0.11 | (0.13) | (0.19) | |
Capex per Share |
(0.06) | (0.07) | (0.09) | (0.10) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(11.48%) | (10.00%) | (9.02%) | (10.67%) |
Columns are period end dates